2014
DOI: 10.1371/journal.pone.0098437 View full text |Buy / Rent full text
|
|

Abstract: ObjectiveTo estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared with trivalent influenza vaccine in the UK.MethodsA lifetime, multi-cohort, static Markov model was constructed, with nine age groups each divided into healthy and at-risk categories. Influenza A and B were accounted for separately. The model was run in one-year cycles for a lifetime (maximum age: 100 years). The analysis was from the perspective of the UK National Health Service. Costs and benefits were discounted… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
4
87
0
2

Publication Types

Select...

Relationship

0
0

Authors

Journals